Publication | Closed Access

A multicenter, randomized, phase III study of docetaxel plus best supportive care versus best supportive care in chemotherapy-naive patients with metastatic or non-resectable localized non-small cell lung cancer (NSCLC)

OncologyCancer ManagementClinical TrialsIii StudyCancer TreatmentMedicineRadiation OncologyCancer ChemotherapyLung CancerChemotherapy-naive PatientsHealth Sciences